A Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas.
Phase of Trial: Phase I/II
Latest Information Update: 31 Jul 2017
At a glance
- Drugs Belinostat (Primary) ; Doxorubicin
- Indications Sarcoma; Soft tissue sarcoma; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors TopoTarget
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 28 May 2015 Results presented at the 2015 American Society of Clinical Oncology Annual Meeting, according to an Onxeo media release.
- 28 May 2015 Results published in an Onxeo media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History